Thomas McCauley - Feb 7, 2024 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGA)

Role
Chief Scientific Officer
Signature
/s/ Barbara Chan as Attorney-in-Fact for Thomas McCauley
Stock symbol
OMGA
Transactions as of
Feb 7, 2024
Transactions value $
$0
Form type
4
Date filed
2/9/2024, 05:14 PM
Previous filing
Mar 2, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMGA Stock Option (Right to Buy) Award $0 +125K $0.00 125K Feb 7, 2024 Common Stock 125K $3.59 Direct F1
transaction OMGA Stock Option (Right to Buy) Award $0 +75K $0.00 75K Feb 7, 2024 Common Stock 75K $3.59 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable with respect to 25% of the underlying shares on February 7, 2025 and in twelve (12) equal quarterly installments thereafter such that the option will become fully vested and exercisable on February 7, 2028, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
F2 The option vests and becomes exercisable in three equal installments on each of October 7, 2024, June 7, 2025 and February 7, 2026, subject to the Reporting Person's continued service to the Issuer through each such vesting date.